Alume Biosciences Inc — Form D/A

Alume Biosciences Inc of LA JOLLA, CA, a company, filed a Form D amendment with the SEC on 2026-02-19. The offering totals $23.5M, of which $6.9M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
Brett BermanRelated PersonLa Jolla, CA
Dan BradburyRelated PersonLa Jolla, CA
Kim KamdarRelated PersonSan Diego, CA
Magda MarquetRelated PersonLa Jolla, CA
Jean-Pierre MillonRelated PersonLa Jolla, CA
Quyen NguyenRelated PersonLa Jolla, CA
Kaveri ParkerRelated PersonLa Jolla, CA
James SchmidtRelated PersonLa Jolla, CA
Kaveri ParkerExecutive OfficerLa Jolla, CA
Magda MarquetDirectorLa Jolla, CA
Kim KamdarDirectorSan Diego, CA
Brett BermanDirectorLa Jolla, CA
Brett BermanExecutive OfficerLa Jolla, CA
James SchmidtExecutive OfficerLa Jolla, CA
Jean-Pierre MillonDirectorLa Jolla, CA
Quyen NguyenDirectorLa Jolla, CA
Quyen NguyenExecutive OfficerLa Jolla, CA
Dan BradburyDirectorLa Jolla, CA
Jean-Pierre T MillonDirectorSan Diego, CA
Kim T KamdarDirectorSan Diego, CA
Magda T MarquetDirectorSan Diego, CA
Brett T BermanDirectorSan Diego, CA
Brett T BermanExecutive OfficerSan Diego, CA
James T SchmidtExecutive OfficerSan Diego, CA
Dan T BradburyDirectorSan Diego, CA

Other filings by this issuer (11)

FiledFormOfferingSold
2026-05-08D/A$8.0M$2.2M
2026-04-06D$8.0M$110K
2026-01-30D/A$23.5M$6.0M
2025-12-31D/A$23.5M$5.3M
2025-11-12D/A$23.5M$3.6M
2025-10-31D$23.5M$3.1M
2023-01-09D$45.0M$12.8M
2022-09-21D/A$5.2M$4.0M
2022-04-15D$5.0M$3.0M
2020-08-26D$4.0M$4.0M
2019-07-11D$8.6M$5.8M

More